Anonymous User
Login
/
Registration
Gastroenterologie
a hepatologie
Gastroenterology and Hepatology
Advanced Search
Home
Articles
Current Issue
Archive
Supplement
In press
For authors
Add article to OJS
Instructions for authors
Instructions for reviewers
Conflict of Interest
How to write a manuscript
About the Journal
Journal information
Editorial Board
International Editorial Board
Editors
Authors
Ethical standards
Subscription
Information for Advertisers
Open-Access Policy
Professional societies
Czech Gastroenterological Society
Slovak Gastroenterological Society
Slovak Hepatological Society
My GH
Login
Registration
Edit Profile
Recently viewed articles
Saved Articles
eAlerts
Tests
OJS
Supplement
2019
Supplementum 1 (2019)
2018
Supplementum 2 (2018)
Supplementum 1 (2018)
2017
Supplementum 2 (2017)
Supplementum 1 (2017)
2016
Supplementum 2 (2016)
Supplementum 1 (2016)
2015
Supplementum 2 (2015)
Supplementum 1 (2015)
2014
Supplementum 2 (2014)
Supplementum 1 (2014)
2013
Supplementum 3 (2013)
Supplementum 2 (2013)
Supplementum 1 (2013)
2012
Supplementum 2 (2012)
Supplementum 1 (2012)
2011
Supplementum 2 (2011)
Supplementum 1 (2011)
2009
Supplementum 1 (2009)
2008
Supplementum 2 (2008)
Supplementum 1 (2008)
2007
Supplementum 2 (2007)
Supplementum 1 (2007)
2006
Supplementum 1 (2006)
2005
Supplementum 2 (2005)
Supplementum 1 (2005)
Credited self-teaching test
Start test
Most Read (last 6 month)
Colorectal cancer screening in the Czech Republic
Pancreatic cancer surveillance in high-risk individuals Position statement of professional societies
Trends in premature mortality from digestive system cancers in Slovakia in the years 2011–2020: 8 diagnoses over 10 years
Results from the evaluation of colorectal cancer screening in the Czech Republic
Mixed adenoneuroendocrine carcinoma of the stomach – a case report
Subcutaneous infliximab in the treatment of refractory Crohn‘s disease patients – a pilot study of drug immunogenicity
Urolithiasis in patients with inflammatory bowel disease – possibilities of prevention and metabolic influence
Subcutaneous infliximab – treatments and new possibilities after clinical practice
Subscription
Contact
Links
For advertisers
Partners
Privacy Policy